Clinical trial
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured…
NCT00182091 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00182091 |
|---|---|
| Title | Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency |
| Official title | Effects of Physiologic Growth Hormone Administration on Cardiovascular Risk in Subjects With Growth Hormone Deficiency Following Cure of Acromegaly |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Acromegaly, Growth Hormone Deficiency, Pituitary Disease |
| Intervention type | Drug |
| Interventions | Recombinant human growth hormone, Saline |
| Enrollment | 75 |
| Start date | Aug 1, 2004 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 2, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: